stars 1 stars 2 stars 3

Akesa Pharma specialises in sourcing commercially registered pharmaceutical products for clinical trials globally. We are an independent fully licensed specialist pharmaceutical wholesaler. Dealing exclusively with the sourcing and procurement of comparator products for the use in clinical trials. Our experienced and professional approach, has made us the partner of choice for clinical trial supply for pharmaceutical and biotech companies, phase I units, clinical research organisations (CRO), research groups and hospitals, clinical development and manufacturing organisations (CDMO) and analytical laboratories. We are committed to delivering medicines to patients for clinical trials in Australia, APAC and across the globe. We provide secure and confidential supply of comparator drugs, access to product documentation and tailored supply chain solutions. We have a clear understanding of clinical trial industry requirements and the ability to navigate the commercial market landscape to fulfil clinical trial needs. We pride ourselves on being responsive and committed to providing the best quality of service to our customers.

Akesa Pharma Questions

The Akesa Pharma annual revenue was $7 million in 2026.

Mayank Maini is the CFO of Akesa Pharma.

1 people are employed at Akesa Pharma.

Akesa Pharma is based in Melbourne, Victoria.

The NAICS codes for Akesa Pharma are [42421, 4242, 424, 42].

The SIC codes for Akesa Pharma are [512, 51].

Top Akesa Pharma Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users